Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
- Status
- COMPLETED
- Phase
- PHASE2
MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- NA
CD-ROM Intervention for Prostate Cancer Screening
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
- Status
- WITHDRAWN
- Phase
- N/A
Family History in Prostate Cancer Patients in Taiwan
- Status
- UNKNOWN
- Phase
- N/A
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
- Status
- TERMINATED
- Phase
- NA
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2